Open Access Policy

The International Journal of Clinical Medicine and Pharmacology (IJCMP) is dedicated to promoting the broadest possible dissemination of research by providing immediate and unrestricted access to all published content. As a fully open-access journal, IJCMP adheres to the following principles:

Unrestricted Access

  • All content published in IJCMP is freely accessible online without charge to readers or their institutions.
  • Users are permitted to:
    • Read, download, copy, distribute, print, search, or link to the full texts of articles.
    • Use the content for any lawful purpose, without the need for prior permission from the publisher or authors, provided proper attribution is given.

No Embargo Period

  • IJCMP follows a no-embargo policy, ensuring all articles are available for free and open access immediately upon publication.

No Registration Requirement

  • Readers do not need to register or log in to access the journal’s content. All articles are openly available without barriers.

Licensing and Copyright

  • Articles are published under the Creative Commons Attribution 4.0 International (CC BY 4.0) license.
  • This license permits unrestricted reuse, distribution, and adaptation of content, as long as proper credit is given to the original authors and source.

Benefits of Open Access

  • For Authors : Authors retain copyright to their work and gain increased visibility, impact, and citation of their research.
  • For Readers : Researchers, students, and the public worldwide have free access to high-quality, peer-reviewed content without financial or technical restrictions.

Commitment to Open Science

  • IJCMP upholds the principles of open science, fostering a collaborative and inclusive global research environment. By removing barriers to access, we aim to advance knowledge-sharing and innovation in the field of social sciences.

For further information on our open access policy, please contact us at contact@press.jandoo.ac .